Upendra Nagaich – Sper Market Research®
View Detailed Executive Profile →Professional Overview
- Upendra Nagaich founded SPER Market Research® in August 2015, establishing a firm dedicated to providing high-quality market research services in the pharmaceutical and healthcare sectors.
- As the CEO of SPER Market Research®, Nagaich has played a critical role in driving innovations in market research methodologies, enhancing the company's reputation within the industry.
- In addition to leading SPER Market Research®, Nagaich has served as the Chief Executive Officer of Viginovix since March 2025, broadening the impact on pharmaceutical research and development.
- Nagaich held the position of National Secretary of the Society of Pharmaceutical Education & Research starting from January 2010, contributing to advancements in pharmaceutical education and policy.
- As the Editor In Chief of the Journal of Advanced Pharmaceutical Technology & Research (JAPTR) since January 2010, Nagaich has influenced pharmaceutical literature and research dissemination.
- Nagaich was appointed as Professor & Head at Amity University, Noida, in January 2014, where significant contributions were made to academic programs and research development until March 2023.
- Previously served as Head of Department at Bharat Institute of Technology from November 2011 until January 2014, effectively leading academic initiatives and department transformation.
- Had a tenure as Principal at BVM College of Pharmacy from February 2008 until October 2011, where development of educational frameworks and student engagement were prioritized.
Professional Experience
| Company | Designation | Period |
|---|---|---|
| Bharat Institute of Technology | Head Of Department | Nov 2011 – Jan 2014 |
| Amity University, Noida | Professor & Head | Jan 2014 – Mar 2023 |
| BVM College of Pharmacy | Principal | Feb 2008 – Oct 2011 |
| Viginovix | Chief Executive Officer | Mar 2025 – Present |
| Society of Pharmaceutical Education & Research | National Secretary | Jan 2010 – Present |
| Journal of Advanced Pharmaceutical Technology & Research (JAPTR) | Editor In Chief | Jan 2010 – Present |
| SPER Market Research® | Founder & CEO | Aug 2015 – Present |
Estimated Net Worth
Estimated Range: ₹0 – ₹1000+ Cr (approx. $0 – $120M+)
Based on publicly accessible filings, industry benchmarks, and leadership compensation patterns.
Executive Contact
Official Email: Via Sper Market Research® corporate communication desk.
Personal Contact: Not publicly disclosed.
Frequently Asked Questions
What is Upendra Nagaich's net worth?
Estimated ₹0 – ₹1000+ Cr (approx. $0 – $120M+).
How can I contact them?
Through Sper Market Research®'s official communication channels.
Is this an official profile?
No — independently created using public data.
Disclaimer
This profile is created for general informational purposes. All details are based on publicly accessible information and independent research. While accuracy is prioritized, content may not always reflect the latest updates.
Nothing here should be interpreted as investment, financial, or legal advice. The individual featured has not authored or endorsed this profile.
Personal information is intentionally withheld. For official matters, please use formal communication channels associated with the respective organization.
Affluense AI – Smarter Insights. Stronger Relationships with Affluents.
Last Updated: December 2025 · Published by Affluense AI (affluense.ai)